Unusual 11 Mid-Day Movers 6/15: JAZZ, AIM, QEPC, CYCC Higher; ODC, LEA, CDII, IRE Lower Jun 15, 2009 12:48PM

Jazz Pharmaceuticals' (Nasdaq: JAZZ) 70.8% HIGHER; sodium oxybate (JZP-6) demonstrated statistically significant and clinically meaningful improvement in pain and the core symptoms associated with fibromyalgia, according to Phase III data presented last week at the 2009 Associated Professional Sleep Societies meeting in Seattle, WA. These data have not been evaluated by the FDA or other regulatory authorities for use of sodium oxybate in the treatment of fibromyalgia.

Aerosonic Corporation (Amex: AIM) 66.2% HIGHER; reports Q1 EPS of $0.38, compared to a loss of $0.07 in the same quarter last year. Revenue for the quarter was $8.77 million, versus $6.65 million ...